1 | 0,5 mg Fingolimod | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
2 | FINGOLIMOD | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 14, 156 💬
|
3 | Fingolimod (FTY720) | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 156 💬
|
4 | Fingolimod 0.5 mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
5 | Fingolimod 0.5mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
6 | Fingolimod 1.25 mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
7 | FINGOLIMOD HYDROCHLORIDE | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬
|
8 | Fingolimodi | - | - | - | - | [1] 13 13 💬
|
9 | Hidrocloruro de fingolimod | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬
| [1] S1PR1 S1PR1 💬
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬
|
10 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | [12] Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | [10] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
,
Dimethyl fumarate
,
Ocrelizumab
,
Natalizumab
,
Ofatumumab
,
Fingolimod
,
Teriflunomide
,
Ponesimod
💬
| [7] CD52 CD52, DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬
| [30] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 | [1] 13 13 💬
|